Email Us
View Reports

Global OTC Drugs and Dietary Supplements Market Analysis with Forecasts to 2022 | Growth Opportunities

  • ID : 1947839572  |  
  • Published : Mar-2017  |  
  • Region : Global  |  
  • Pages : 150   |  
  • Publisher : BCC Research

Report Scope:

The report considers only western or modern drugs for this report and excludes any other type of drugs such as alternative therapies.

This study aims at understanding the dynamics and forecasts for OTC drugs and dietary supplements markets worldwide and provides key market propositions within the next five-year period.

The report covers developed and emerging markets in order to help readers understand -

- The current state of the OTC drugs and dietary supplements market and the key markets for its future development.

- New regulations that will influence the development of the OTC drugs and dietary supplements market.

- Market drivers of and threats to the OTC drugs and dietary supplements industry.

- Major regional trends in the global OTC drugs and dietary supplements market.

Report Includes:

- An overview of the global markets for OTC drugs and dietary supplements

- Analyses of global market trends, with data from 2015, 2016, and projections of CAGRs through 2021

- Information about how pharmacies affect the OTC drug market

- Analysis of new developments that will provide an opportunity to manufacturers and marketers of OTC medicines and dietary supplements to expand organically

- Updates on the latest merger and acquistion activity

- Coverage of how point of sales and channels of distribution drive sales of OTC drugs and dietary supplements

- A look at key strategic initiatives for market penetration and expansion

- Company profiles of major players in the field

Table of Contents

Chapter 1 INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

SCOPE OF REPORT

INTENDED AUDIENCE

INFORMATION SOURCES

ANALYST'S CREDENTIALS

RELATED BCC RESEARCH REPORTS

BCC RESEARCH WEBSITE

DISCLAIMER

Chapter 2 SUMMARY

Chapter 3 OVERVIEW

Chapter 4 GLOBAL OTC DRUGS AND DIETARY SUPPLEMENT MARKETS

Chapter 5 OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN THE AMERICAS

Chapter 6 THE OTC DRUG AND DIETARY SUPPLEMENT MARKETS IN EUROPE

Chapter 7 OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN ASIA-PACIFIC

Chapter 8 GLOBAL MARKET FORECAST FOR OTC DRUGS BY THERUPEUTIC CLASSIFICATION

Chapter 9 OTC DRUG INDUSTRY ROADMAP

Chapter 10 COMPANY PROFILES

GLOBAL OTC DRUG MARKETS BY LEADING THERAPEUTIC SEGMENTS, 2016 THROUGH 2021

GLOBAL DIETARY SUPPLEMENT MARKETS, 2016 THROUGH 2021

EVOLUTION OF OTC DRUGS

KEY GROWTH FACTORS FOR OTC DRUGS AND DIETARY SUPPLEMENT MARKETS

INDUSTRY DRIVERS FOR OTC DRUGS

RULES AND REGULATIONS FOR OTC DRUGS AND DIETARY SUPPLEMENTS

MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS

PREVALENCE OF SELF-CARE

BURDEN ON PUBLIC HEALTH SYSTEM

RETAIN MARKET LEADERSHIP

REGULATIONS FOR OTC DRUGS

REGULATIONS FOR DIETARY SUPPLEMENTS

WELL-DEVELOPED MARKETS

DEVELOPING MARKETS

UNDER-DEVELOPED MARKETS

GLOBAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS 2016 THROUGH 2021

REGIONAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENT MARKETS 2016 THROUGH 2021

GLOBAL SALES FORECAST FOR OTC DRUGS BY THERUPEUTIC CLASSIFICATION

GLOBAL OTC DRUGS AND DIETARY SUPPLEMENT MARKETS BY LOCATION OF SALES 2016 THROUGH 2021

GLOBAL MARKET FORECAST FOR OTC DRUGS AND DIETARY SUPPLEMENTS BY SALES OUTLETS, THROUGH 2021

OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN NORTH AMERICA 2016 THROUGH 2021

OTC DRUGS AND DIETARY SUPPLEMENTS IN THE U.S.

VENDOR ECOSYSTEM FOR OTC DRUGS IN THE U.S.

NORTH AMERICA OTC DRUGS MARKETS 2016 THROUGH 2021

NORTH AMERICA DIETARY SUPPLEMENT MARKETS 2016 THROUGH 2021

NORTH AMERICA OTC DRUGS MARKETS BY THERAPEUTIC CLASSIFICATION 2016-2021

NORTH AMERICA OTC DRUGS MARKETS BY THERAPEUTIC CLASSIFICATION 2016 THROUGH 2021

MULTINATIONAL OTC DRUG MANUFACTURERS

STORE BRANDS

FMCG COMPANIES

REGULATIONS AND APPROVAL PROCESS: THE U.S.

THE U.S. NONPRESCRIPTION SAFE-USE REGULATORY EXPANSION (NSURE) INITIATIVE

THE U.S. OTC DRUGS AND DIETARY SUPPLEMENT MARKET 2016-2021

BRAZIL OTC DRUGS MARKET

BRAZIL OTC DRUGS MARKET 2016 THROUGH 2021

Drugs Developed Under the OTC Drug Monograph Process

OTC Drugs Developed Through the NDA Process

Updated List of Prescription to Over-the-Counter (OTC) Switches

OTC Drug Review

OTC Monograph

BREXIT EFFECT ON THE OTC DRUG MARKET IN EUROPE

OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN EUROPE 2016 - 2021

OTC DRUGS AND DIETARY SUPPLEMENT MARKETS: WESTERN EUROPE THROUGH 2021

THE U.K. OTC DRUG MARKET

GERMAN OTC DRUG AND DIETARY SUPPLEMENTS MARKET

FRANCE'S OTC DRUGS MARKET 2016 THROUGH 2021

OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN CENTRAL AND EASTERN EUROPE

REGULATIONS AND APPROVAL PROCESS IN EUROPE

SMART REGULATION 2015: EUROPE AS A SINGLE MARKET

EUROPEAN OTC DRUGS AND DIETARY SUPPLEMENT MARKETS 2016 - 2021

THE REGULATIONS AND APPROVAL PROCESS IN THE U.K.

POM TO P RECLASSIFICATIONS UP TO OCTOBER 2016

POM TO P RECLASSIFICATIONS IN THE U.K. APPROVED FROM 2010 TO 2015

U.K. OTC DRUGS AND DIETARY SUPPLEMENT MARKET 2016 THROUGH 2021

THE REGULATIONS AND APPROVAL PROCESS IN GERMANY

OTC DRUG SWITCHES IN GERMANY FROM 2005 TO 2016

GERMAN OTC MARKET 2016 THROUGH 2021

THE RUSSIAN OTC DRUG MARKET 2016 THROUGH 2021

THE POLISH OTC DRUG MARKET 2016 THROUGH 2021

National Procedure

Decentralized Procedure

Mutual Recognition Procedure

Centralized Procedure

Better Regulation of Over-the-Counter Drugs Initiative (BROMI) U.K.

APAC OTC DRUGS MARKETS 2016 THROUGH 2021

JAPAN'S OTC DRUGS MARKET

JAPAN'S OTC DRUGS MARKET 2016 THROUGH 2021

CHINA OTC DRUG MARKETS 2016 THROUGH 2021

THE REGULATION AND APPROVAL PROCESS: CHINA

CHINA - OTC DRUGS MARKET 2016 THROUGH 2021

INDIA OTC DRUG MARKETS

INDIA: REGULATION AND APPROVAL PROCESSES

INDIA - OTC DRUGS MARKET 2016 THROUGH 2021

AUSTRALIA AND NEW ZEALAND'S OTC DRUGS MARKET

NEW ZEALAND

JOINT AUSTRALIAN AND NEW ZEALAND PHASED IMPLEMENTATION PLAN 2013

AUSTRALIA AND NEW ZEALAND: OTC DRUGS MARKET 2016 THROUGH 2021

The Regulation and Approval Process in Japan

Reviews Conducted for OTC Drugs In Japan, by Fiscal Year

First Kind Pharmaceutical Newly Approved - Japan's OTC Pharmaceutical Sales System

New Amendments in Regulating Drug Advertising in 2015

Regulation and Approval Process: Australia

N2 Applications (Using OTC Monographs) Version1, September 2013

Level N3, N4 and N5 Applications

OTC ANALGESICS/ANTIPYRETICS MARKETS 2021

OTC ANTIHISTAMINE AND COUGH AND COLD DRUGS MARKETS 2021

OTC GASTROINTESTINAL PRODUCTS MARKETS 2021

OTC DERMATOLOGICAL DRUGS MARKETS 2021

OTC ORAL MEDICAL CARE PRODUCTS MARKETS 2021

GLOBAL MARKET FORECAST FOR OTC EYE CARE PRODUCTS

OTC SMOKING CESSATION PRODUCTS MARKETS 2021

OTC DIETARY SUPPLEMENTS (VMS) MARKETS 2021

GLOBAL MARKET FORECAST THROUGH 2021

ACETAMINOPHEN

NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)

MARKET FORECASTS 2016 THROUGH 2021

ANTIHISTAMINES

COUGH AND COLD REMEDIES

GLOBAL MARKET FORECASTS THROUGH 2021

GASTROINTESTINAL DISORDER TREATMENTS

GLOBAL MARKET FORECAST FOR THROUGH 2021

SKINCARE AND DERMATOLOGICAL DRUGS

GLOBAL MARKET FORECAST THROUGH 2021

ORAL MEDICAL CARE

GLOBAL MARKET FORECAST FOR THROUGH 2021

EYE CARE PRODUCTS

GLOBAL MARKET FORECAST THROUGH 2021

SMOKING CESSATION

GLOBAL MARKET FORECAST FOR OTC SMOKING CESSATION PRODUCTS BY REGION THROUGH 2021

EATING DISORDERS

TREATMENTS FOR VITAMINS AND MINERAL DEFICIENCY

VITAMINS AND MINERAL SUPPLEMENTS (VMS)

Nasal Decongestants

Cough Remedies

Antacids

H2 Blockers

Proton Pump Inhibitors (PPIs)

Acne Treatments

Psoriasis

Oral Debriding Agents and Wound Cleansers

Treatments for Dental Carries

Treatments on Gum Diseases

Treatments for Cold Sores

Treatments for Dry Eye

Ocular Allergy Symptoms

Ocular/Eye Vitamins

Eyelid Hygiene

Contact Lenses Solution

Dry Eye

Nicotine Gum

Nicotine Lozenges

Nicotine Patch

THE PRACTICE OF BUYING OTC DRUGS

ROLE OF PHARMACY IN OTC DRUGS

REGULATORY INFLUENCE ON OTC DRUG MARKET

KEY STRATEGIC INITIATIVES FOR MARKET PENETRATION AND EXPANSION

DRIVERS OF AND BARRIERS TO THE OTC DRUG INDUSTRY

STRENGTHS, WEAKNESSES, OPPORTUNITIES AND THREATS (SWOT) ANALYSIS OF THE OTC DRUG AND DIETARY SUPPLEMENT INDUSTRY

ACQUISITION OF MARKETING AUTHORIZATION: KEY MARKET PENETRATION AND EXPANSION STRATEGY

EXPANSIONS, PARTNERSHIPS AND JOINT VENTURES

THIRD-PARTY CONTRACTING

RECENT DRIVERS FOR THE OTC DRUGS AND DIETARY SUPPLEMENT MARKET

Chapter 11 APPENDIX I

Chapter 12 APPENDIX II

Chapter 13 APPENDIX III

MARKET DEFINITIONS

COMMON ADMINISTRATION METHODS FOR OTC DRUGS

OTC DRUGS

DIETARY SUPPLEMENTS (VMS)

TOPICAL ADMINISTRATION

ORAL ADMINISTRATION

Lotion

Cream

Ointment

Gel

Transdermal Patch

Tablets

Capsules

Medicinal Syrups

Medicated Chewing Gums

SMOKING CESSATION INITIATIVES

HIGH RATE OF SMOKERS QUITTING IN DEVELOPED COUNTRIES

DECREASE IN SMOKING RATES AT SATURATION POINT IN DEVELOPED MARKETS

SMOKING RATES ARE INCREASING IN DEVELOPING MARKETS

STRATEGIC INITIATIVES TO INCREASE SMOKING CESSATION IN DEVELOPING COUNTRIES

DEVELOPING AND POOR COUNTRIES SIGN WHO FCTC TREATY

WHO FCTC PROGRESS REPORT 2012

Implementation of Article 14 in 2012

Political and Legal Interventions Influence Markets

Socioeconomic Factors of Smoking

Technological Developments Concerning Smoking

OTC MARKETS 2013 THROUGH 2018

HIGHLIGHTS OF THE YEAR 2012

TRENDS IN OTC DRUGS AND DIETARY SUPPLEMENTS THROUGH 2018

FORECAST TRENDS IN OTC DRUGS BY THERAPEUTIC CLASS THROUGH 2018

ALACER CORP.

ALCON INC.

ALFRESA PHARMA CORPORATION

ALKALON A/S

ALLIANCE HEALTHCARE

ALLERGAN, PLC.

ALTICOR

ARKOPHARMA PHARMACEUTICAL LABORATORIES (LABORATOIRES PHARMACEUTIQUES)

ASPEN HOLDINGS

ASPEN PHARMACARE AUSTRALIA PTY. LTD.

BAUSCH & LOMB

BAYER HEALTHCARE AG

BOEHRINGER INGELHEIM GMBH

CARMA LABORATORIES, INC.

CHATTEM INC.

CILAG AG

COLGATE-PALMOLIVE COMPANY

DAIICHI SANKYO CO., LTD.

DERMA SCIENCES

EYESCIENCE LABS

FERTIN PHARMA A/S

GABA GMBH, PC

GALDERMA S.A.

GEMINI PHARMACEUTICALS, INC.

GENOMMA LAB INTERNATIONAL

GLAXOSMITHKLINE PLC

HISAMITSU PHARMACEUTICAL CO., INC.

JOHNSON & JOHNSON

KOWA COMPANY, LTD.

LAKE CONSUMER PRODUCTS, INC.

MANX HEALTHCARE LIMITED

MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)

MEDA AB

MELALEUCA, INC.

MERCK CORPORATE HEADQUARTERS

MERCK CANADA

MERCK CHINA

MERZ PHARMA

MOCHIDA PHARMACEUTICAL CO., LTD.

NEPENTES SA/NEPENTES PHARMA SP. Z O.O.

NEUTROGENA CORP.

NORTHEAST PHARMACEUTICAL GROUP CO. LTD

NOVARTIS INTERNATIONAL AG

NOW FOODS

PERRIGO PLC

PFIZER INC.

PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE)

PHARMAVITE LLC

PIERRE FABRE PHARMACEUTICALS INC.

PIRAMAL HEALTHCARE LTD

PRESTIGE BRANDS HOLDINGS, INC.

RECKITT BENCKISER PLC.

RECKITT BENCKISER (NORTH AMERICA) INC.

RECORDATI PHARMA GMBH

REVOLYMER (U.K.) LTD

SAGE PRODUCTS LLC

SANOFI

SATO PHARMACEUTICAL CO., LTD.

SHAKLEE CORPORATION

STADA ARZNEIMITTEL AG

SWISSE WELLNESS PTY LTD.

TAISHO PHARMACEUTICAL HOLDINGS

TAKEDA PHARMACEUTICALS LTD.

TISSO NATURPRODUKTE GMBH

WELLSPRING PHARMACEUTICAL CORPORATION

ZEAVISION, LLC

ALLIANCE HEALTHCARE DEUTSCHLAND

ALLIANCE HEALTHCARE FRANCE

NUTRILITE

GABA SCHWEIZ

GENOMMA LAB USA

List of Tables

Summary Table A : GLOBAL THERAPEUTIC MARKETS FOR OTC DRUGS, BY SEGMENT, THROUGH 2021

Summary Table B : REGIONAL MARKETS FOR DIETARY SUPPLEMENTS, THROUGH 2021

Table 1 : GLOBAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS, THROUGH 2021

Table 2 : REGIONAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS THROUGH 2021

Table 3 : GLOBAL MARKET FOR OTC DRUGS, BY THERUPEUTIC CLASSIFICATION, THROUGH 2021

Table 4 : OTC DRUGS REVENUE BY LOCATION OF SALES, THROUGH 2021

Table 5 : DIETARY SUPPLEMENTS REVENUE BY LOCATION OF SALES, THROUGH 2021

Table 6 : NORTH AMERICA OTC DRUG MARKETS, THROUGH 2021

Table 7 : NORTH AMERICA DIETARY SUPPLEMENT MARKETS, THROUGH 2021

Table 8 : NORTH AMERICA MARKETS BY THERAPEUTIC CLASSIFICATION, THROUGH 2021

Table 9 : UPDATED LIST OF RX-TO-OTC SWITCHES IN THE U.S. FROM 2001 TO 2016

Table 10 : THE U.S. OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021

Table 11 : BRAZIL OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 12 : EUROPEAN OTC DRUG MARKETS, THROUGH 2021

Table 13 : EUROPEAN OTC DRUG MARKETS BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021

Table 14 : U.K. POM TO P RECLASSIFICATIONS UP TO OCTOBER 2016

Table 15 : P TO GSL RECLASSIFICATIONS UP TO OCTOBER 2016

Table 16 : RECENT POM TO P RECLASSIFICATIONS AND NONPRESCRIPTION MARKETING AUTHORIZATIONS: U.K., 2010-2015

Table 17 : RECENT P TO GSL RECLASSIFICATIONS AND NONPRESCRIPTION MARKETING AUTHORIZATIONS - U.K., 2011-2015

Table 18 : THE U.K. OTC DRUG MARKET, BY THERAPEUTIC CLASSIFICATION, THROUGH 2021

Table 19 : OTC DRUG SWITCHES IN GERMANY FROM 2005 TO 2016

Table 20 : GERMANY OTC DRUG MARKETS BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021

Table 21 : FRANCE OTC DRUG MARKETS BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021

Table 22 : CCE OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021

Table 23 : RUSSIAN OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 24 : POLISH OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 25 : APAC OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 26 : REVIEWS CONDUCTED FOR OTC DRUGS IN JAPAN, BY FISCAL YEAR, 2011-2015

Table 27 : UPDATED LIST OF OTC TO FIRST KIND PHARMACEUTICAL DRUGS IN JAPAN, NOV. 2007-MARCH 2016

Table 28 : JAPAN OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 29 : CHINA OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 30 : INDIA OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 31 : AUSTRALIA AND NEW ZEALAND OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021

Table 32 : GLOBAL MARKET FORECAST FOR OTC ANALGESICS AND ANTIPYRETICS, THROUGH 2021

Table 33 : GLOBAL MARKET FORECAST FOR OTC ANTIHISTAMINE AND COUGH AND COLD, THROUGH 2021

Table 34 : GLOBAL MARKET FORECAST FOR OTC GASTROINTESTINAL PRODUCTS, THROUGH 2021

Table 35 : GLOBAL MARKET FORECAST FOR OTC DERMATOLOGICAL DRUGS, THROUGH 2021

Table 36 : GLOBAL MARKET FORECAST FOR OTC ORAL MEDICAL CARE PRODUCTS THROUGH 2021

Table 37 : GLOBAL MARKET FORECAST FOR OTC EYE CARE PRODUCTS, THROUGH 2021

Table 38 : GLOBAL MARKET FORECAST FOR OTC SMOKING CESSATION PRODUCTS, BY REGION, THROUGH 2021

Table 39 : GLOBAL MARKET FORECAST FOR OTC DIETARY SUPPLEMENT PRODUCTS, BY REGION, THROUGH 2021

Table 40 : SWOT ANALYSIS OF THE OTC DRUG AND DIETARY SUPPLEMENT INDUSTRY

Table 41 : ARTICLES REPORTED TO HAVE HIGHEST IMPLEMENTATION RATES IN 2012 WHO FCTC PROGRESS REPORT

Table 42 : ARTICLES REPORTED MODERATE IMPLEMENTATION RATES: 2012 WHO FCTC PROGRESS REPORT

Table 43 : ARTICLES REPORTED LOWEST IMPLEMENTATION RATES: 2012 WHO FCTC PROGRESS REPORT

Table 44 : GLOBAL IMPLEMETATION OF FCTC ARTICLES: 2012 REPORT

Table 45 : GLOBAL IMPLEMENTATION OF ARTICLE 14 OF FCTC

Table 46 : INITIATIVES IMPLEMENTED BY PARTIES TO FCTC TREATY IN 2012

Table 47 : PROJECTED GLOBAL CAUSE OF DEATH BY DISEASE

Table 48 : PUBLIC HEALTH BURDEN DUE TO SMOKING-RELATED DISEASES

Table 49 : GLOBAL MARKET FOR OTC DRUGS AND DIETARY SUPPLEMENTS THROUGH 2018

List of Figures

Summary Figure A : GLOBAL THERAPEUTIC MARKETS FOR OTC DRUGS, BY SEGMENT, 2015-2021

Summary Figure B : REGIONAL MARKETS FOR DIETARY SUPPLEMENTS, 2015-2021

Figure 1 : KEY GROWTH FACTORS FOR OTC DRUGS

Figure 2 : GLOBAL IMPLEMENTATION OF ARTICLES OF 2012 WHO FCTC PROGRESS REPORT

Figure 3 : ONGOING STUDIES, BY REGION

Figure 4 : GLOBAL MARKET FOR OTC DRUGS AND DIETARY SUPPLEMENTS, 2011-2018

Purchase this Market Research Report

  • SINGLE USER LICENSE
    Single user license allows one specific user to access the product.
  • TEAM LICENSE
    Team License allows multiple users to access the product.
  • CORPORATE LICENSE
    Corporate License allows users across the whole organization to access the product.

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?